NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE80508 Query DataSets for GSE80508
Status Public on Apr 30, 2017
Title Epigenetic minicircuitry of AML1-ETO/THAP10/MIR383 contributes t(8;21) AML leukemogenesis
Organism Homo sapiens
Experiment type Methylation profiling by array
Methylation profiling by genome tiling array
Summary AML1-ETO is regarded as an initial event and plays a pivotal role in t(8;21) acute myeloid leukemia (AML) which is a highly heterogeneous disease. DNA methylation patterns are frequently deregulated in t(8;21) AML, though little is known of the mechanisms through which specific gene sets become aberrantly methylated. Here, We found that the promoter DNA methylation signature of t(8;21) AML blasts differs from those of normal CD34+ bone marrow cells and other AMLs. This signature contains 408 differentially methylated genes, many of which are genes involved in cancer pathway and myeloid leukemia. Database systematic survey and differential methylated regions (DMR) analysis were performed. These study demonstrated that a novel hypermethylated zinc finger containing protein-THAP10 is a target gene and can be epigenetic silenced by AML1-ETO at transcriptional level in t(8;21) AML and silencing of THAP10 by AML1-ETO predicts a poor clinical outcome. Our findings also identified that THAP10 is a bona fide target of miR-383 which can be epigenetic activated by AML1-ETO. In this study, we provided evidence that epigenetic silencing of THAP10 is the mechanistic link between AML1-ETO fusion proteins and tyrosine kinase cascades. In addition, we showed that THAP10 is a nuclear protein which inhibits myeloid proliferation inhibition and promotes differentiation both in vitro and in vivo. Altogether, our results revealed an unexpected and important link between fusion protein AML1-ETO, mir-383, THAP10 and tyrosine cascades in t(8;21) AML.
 
Overall design Bisulphite converted DNA from the 12 samples were hybridised to the Illumina HumanMethylation450 BeadChip, including 5 t(8;21)-positive AML, 5 t(8;21)-negative AML M2 subtype according FAB and 2 normal bone marrow.
 
Contributor(s) Li Y, Shi J
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 21, 2016
Last update date Mar 22, 2019
Contact name Shi Long
E-mail(s) csjl@sohu.com
Phone 1012347654
Organization name NDUT
Street address Road One
City Beijing
State/province Peking
ZIP/Postal code 100000
Country China
 
Platforms (1)
GPL13534 Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482)
Samples (12)
GSM2128890 Bone Marrow-diagnosis 1
GSM2128891 Bone Marrow-diagnosis 2
GSM2128892 Bone Marrow-diagnosis 3
Relations
BioProject PRJNA319156

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE80508_RAW.tar 183.1 Mb (http)(custom) TAR
GSE80508_signal_intensities.txt.gz 80.1 Mb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap